The Liquid Embolic Market in the U.S. is shaped by commercial priorities centered on clinical outcomes, product differentiation, multi-center training, and procurement strategy. Device manufacturers are refining formulations to deliver better radiopacity, deeper penetration control, and catheter safety to improve procedural confidence. For commercial strategy insights, visit the Liquid Embolic...